NAD+ and its precursors are among the most actively researched compounds in modern longevity science, with a growing body of human trial data — primarily for NMN and NR rather than NAD+ itself. NAD+ administration in research contexts is studied in a range of formulations, with delivery and stability being practical considerations.
The NAD+ literature is one of the largest in current ageing and metabolic biology:
Ageing research: Documented age-related NAD+ decline across multiple tissues and species.
Sirtuin biology: Extensive investigation of NAD+-dependent sirtuin activity in metabolic regulation, DNA repair, and stress response.
Mitochondrial function: Studies on NAD+ availability and mitochondrial biogenesis.
NAD+ precursors: Parallel research on NMN and NR as repletion strategies, with multiple completed human trials.
Metabolic disease: Investigation in obesity, type 2 diabetes, and metabolic syndrome models.
Neurodegeneration: Studies in Alzheimer's, Parkinson's, and other neurodegenerative models.